HSBC Holdings’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,380
Closed -$15.1K 2875
2023
Q2
$15.1K Hold
1,380
﹤0.01% 2525
2023
Q1
$15.8K Hold
1,380
﹤0.01% 2618
2022
Q4
$11.6K Sell
1,380
-23
-2% -$202 ﹤0.01% 3028
2022
Q3
$11K Sell
1,403
-154
-10% -$1.71K ﹤0.01% 2886
2022
Q2
$18K Hold
1,557
﹤0.01% 3196
2022
Q1
$25K Hold
1,557
﹤0.01% 3231
2021
Q4
$72K Buy
+1,557
New +$89.5K ﹤0.01% 3175
2021
Q1
Sell
-1,352
Closed -$229K 3184
2020
Q4
$229K Buy
+1,352
New +$240K ﹤0.01% 2733

Other funds holding TECX

HSBC Holdings's TECX Position: Q3 2023 in Review

HSBC Holdings sold out of Tectonic Therapeutic (TECX) in Q3 2023, closing a stake of 1,380 shares — an estimated $15.1K sold.

HSBC Holdings first reported a position in TECX in Q4 2020 and held it in 8 quarters. The position peaked at $229K in Q4 2020. 47 funds tracked by Wall St. Rank hold TECX as of Q3 2023.

  • HSBC Holdings reported no remaining Tectonic Therapeutic position as of Q3 2023 after selling out during the quarter.
  • HSBC Holdings sold 1,380 Tectonic Therapeutic shares in Q3 2023, an estimated $15.1K.
  • HSBC Holdings first reported a position in Tectonic Therapeutic in Q4 2020 and held it in 8 quarters.
  • HSBC Holdings's Tectonic Therapeutic position peaked at $229K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.